Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

7 Energy Stocks to Buy as Oil Booms

By Chris Lau, InvestorPlace Contributor

Oil prices are booming and energy stocks are mostly at 52-week highs. As a bonus, many big names offer a high dividend yield.

Price Hikes Will Drive Netflix Stock Higher

By Chris Lau, InvestorPlace Contributor

High valuations in Netflix stock have never scared investors away. Plus, with price hikes and new content on the way, its prospects look good.

Cannabis Stocks to Watch Ahead of the States Bill

By Chris Lau, InvestorPlace Contributor

For cannabis stocksm the States Bill could mean the Federal government stepping out of the way -- and providing new tailwinds.

Buy CVS Health As the Stock Hovers Near 52-Week Lows

By Chris Lau, InvestorPlace Contributor

Governments are looking closely at drug pricing and health plans, putting pressure on the drug store sector. Why look at CVS stock, then?

Why Tandem Diabetes Stock Will Rally Much Further

By Chris Lau, InvestorPlace Contributor

Tandem reported solid Q4 numbers, and TNDM stock has multiple, other potential positive catalysts.

Load More